Epithelial Antimicrobial Molecules

The Pulmonary Epithelium in Health and Disease

Volumn , Issue , 2008, Pages 187-200

  Hiemstra, Pieter S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Airway epithelium and antimicrobial molecules; Antimicrobial peptides and proteins (AMPs); Epithelial antimicrobial molecules; Human neutrophil peptides (HNP); Palate lung nasal clone (PLUNC); Peptidoglycan recognition proteins (PGLYRPs); Reactive oxygen and nitrogen intermediates; Secretory leukocyte protease inhibitor (SLPI)

Indexed keywords

EID: 84890659467     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470727010.ch10     Document Type: Chapter

References (72)

1. Aarbiou, J., Verhoosel, R. M., van Wetering, S., de Boer, W. I., van Krieken, J. H., Litvinov, S. V., Rabe, K. F., & Hiemstra, P. S. (2004) Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro, Am J Respir Cell Mol Biol, 30, 193-201.
2. Arnold, R. R., Cole, M. F., & McGhee, J. R. (1977) A bactericidal effect for human lactoferrin, Science, 197, 263-265.
3. Arnold, R. R., Russell, J. E., Champion, W. J., Brewer, M., & Gauthier, J. J. (1982) Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation, Infect Immun, 35, 792-799.
4. Bals, R. & Hiemstra, P. S. (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens, Eur Respira J, 23, 327-333.
5. Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., & Wilson, J. M. (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide, Infect Immun, 67, 6084-6089.
6. Bals, R. & Wilson, J. M. (2003) Cathelicidins-a family of multifunctional antimicrobial peptides, Cell Mol Life Sci, 60, 711-720.
7. Bals, R., Weiner, D. J., Meegalla, R. L., Accurso, F., & Wilson, J. M. (2001) Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid, Am J Respir Cell Mol Biol, 25, 21-25.
8. Beisswenger, C., Kandler, K., Hess, C., Garn, H., Felgentreff, K., Wegmann, M., Renz, H., Vogelmeier, C., & Bals, R. (2006) Allergic airway inflammation inhibits pulmonary antibacterial host defense, J Immunol, 177, 1833-1837.
9. Bingle, L., Cross, S. S., High, A. S., Wallace, W. A., Devine, D. A., Havard, S., Campos, M. A., & Bingle, C. D. (2005) SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype, J Pathol, 205, 491-497.
10. Bogdan, C., Rollinghoff, M., & Diefenbach, A. (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity, Curr Opin Immun, 12, 64-76.
11. Cole, A. M., Ganz, T., Liese, A. M., Burdick, M. D., Liu, L., & Strieter, R. M. (2001) Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity, J Immunol, 167, 623-627.
12. Conner, G. E., Salathe, M., & Forteza, R. (2002) Lactoperoxidase and hydrogen peroxide metabolism in the airway, Am J Respir Crit Care Med, 166, S57-S61.
13. Davidson, D. J., Currie, A. J., Reid, G. S. D., Bowdish, D. M. E., MacDonald, K. L., Ma, R. C., Hancock, R. E. W., & Speert, D. P. (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization, J Immunol, 172, 1146-1156.
14. De Jongh, G. J., Zeeuwen, P. L., Kucharekova, M., Pfundt, R., van der Valk, P. G., Blokx, W., Dogan, A., Hiemstra, P. S., van de Kerkhof, P. C., & Schalkwijk, J. (2005) High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis, J Invest Dermatol, 125, 1163-1173.
15. Dubin, R. F., Robinson, S. K., & Widdicombe, J. H. (2004) Secretion of lactoferrin and lysozyme by cultures of human airway epithelium, Am J Physiol Lung Cell Mol Physiol, 286, L750-L755.
16. Dziarski, R. & Gupta, D. (2006) Mammalian PGRPs: novel antibacterial proteins, Cell Microbiol, 8, 1059-1069.
17. Felgentreff, K., Beisswenger, C., Griese, M., Gulder, T., Bringmann, G., & Bals, R. (2006) The antimicrobial peptide cathelicidin interacts with airway mucus, Peptides, 27, 3100-3106.
18. Fleming, A. (1922) On a remarkable bacteriolytic element found in tissues and secretions, Proc Roy Soc London, 93, 306-310.
19. Frye, M., Bargon, J., Dauletbaev, N., Weber, A., Wagner, T. O., & Gropp, R. (2000) Expression of human alpha-defensin 5 (HD5) mRNA in nasal and bronchial epithelial cells, J Clin Pathol, 53, 770-773.
20. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity, Nature Rev Immunol, 3, 710-720.
21. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K., & Leto, T. L. (2003) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense, FASEB J, 17, 1502-1504.
22. Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) Human β-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in cystic fibrosis, Cell, 88, 553-560.
23. Gombart, A. F., Borregaard, N., & Koeffler, H. P. (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3, FASEB J, 19, 1067-1077.
24. Heilborn, J. D., Nilsson, M. F., Kratz, G., Weber, G., Sorensen, O., Borregaard, N., & Stahle- Backdahl, M. (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium, J Invest Dermatol, 120, 379-389.
25. Herasimenka, Y., Benincasa, M., Mattiuzzo, M., Cescutti, P., Gennaro, R., & Rizzo, R. (2005) Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens, Peptides, 26, 1127-1132.
26. Hiemstra, P. S., Maassen, R. J., Stolk, J., Heinzel-Wieland, R., Steffens, G. J., & Dijkman, J. H. (1996) Antibacterial activity of antileukoprotease, Infect Immun, 64, 4520-4524.
27. Hollox, E. J., Armour, J. A., & Barber, J. C. (2003) Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster, Am J Hum Genet, 73, 591-600.
28. Hu, R. C., Xu, Y. J., Zhang, Z. X., Ni, W., & Chen, S. X. (2004) Correlation of HDEFB1 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population, Chin Med J (Engl), 117, 1637-1641.
29. Hucke, C., MacKenzie, C. R., Adjogble, K. D. Z., Takikawa, O., & Daubener, W. (2004) Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase, Infect Immun, 72, 2723-2730.
30. Jia, H. P., Schutte, B. C., Schudy, A., Linzmeier, R., Guthmiller, J. M., Johnson, G. K., Tack, B. F., Mitros, J. P., Rosenthal, A., Ganz, T., & McCray, P. B., Jr. (2001) Discovery of new human beta-defensins using a genomics-based approach, Gene, 263, 211-218.
31. Khine, A. A., Del Sorbo, L., Vaschetto, R., Voglis, S., Tullis, E., Slutsky, A. S., Downey, G. P., & Zhang, H. (2006) Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway, Blood, 107, 2936-2942.
32. Leung, T. F., Li, C. Y., Liu, E. K., Tang, N. L., Chan, I. H., Yung, E., Wong, G. W., & Lam, C. W. (2006)Asthma and atopy are associated with DEFB1 polymorphisms in Chinese children, Genes Immun, 7, 59-64.
33. Levy, H., Raby, B. A., Lake, S., Tantisira, K. G., Kwiatkowski, D., Lazarus, R., Silverman, E. K., Richter, B., Klimecki, W. T., Vercelli, D., Martinez, F. D., & Weiss, S. T. (2005) Association of defensin beta-1 gene polymorphisms with asthma, J Allergy Clin Immunol, 115, 252-258.
34. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., Kamen, D. L., Wagner, M., Bals, R., Steinmeyer, A., Zugel, U., Gallo, R. L., Eisenberg, D., Hewison, M., Hollis, B. W., Adams, J. S., Bloom, B. R., & Modlin, R. L. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science, 311, 1770-1773.
35. Matsushita, I., Hasegawa, K., Nakata, K., Yasuda, K., Tokunaga, K., & Keicho, N. (2002) Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease, Biochem Biophysi Res Commun, 291, 17-22.
36. Moser, C., Weiner, D. J., Lysenko, E., Bals, R., Weiser, J. N., & Wilson, J. M. (2002) beta-Defensin 1 contributes to pulmonary innate immunity in mice, Infect Immun, 70, 3068-3072.
37. Moskwa, P., Lorentzen, D., Excoffon, K. J. D. A., Zabner, J., McCray, P. B., Jr., Nauseef, W. M., Dupuy, C., & Banfi, B. (2007) A novel host defense system of airways is defective in cystic fibrosis, Am J Respir Crit Care Med, 175, 174-183.
38. Nagaoka, I., Tamura, H., & Hirata, M. (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7, J Immunol, 176, 3044-3052.
39. Nash, J. A., Ballard, T. N., Weaver, T. E., & Akinbi, H. T. (2006) The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo, J Immunol, 177, 519-526.
40. Nomura, I., Goleva, E., Howell, M. D., Hamid, Q. A., Ong, P. Y., Hall, C. F., Darst, M. A., Gao, B. F., Boguniewicz, M., Travers, J. B., & Leung, D. Y. M. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes, J Immunol, 171, 3262-3269.
41. Nordahl, E. A., Rydengard, V., Nyberg, P., Nitsche, D. P., Morgelin, M., Malmsten, M., Bjorck, L., & Schmidtchen, A. (2004) Activation of the complement system generates antibacterial peptides, Proc Natl Acad Sci U S A, 101, 16879-16884.
42. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis, N Engl J Med, 347, 1151-1160.
43. Oppenheim, J. J. & Yang, D. (2005) Alarmins: chemotactic activators of immune responses, Curr Opin Immunol, 17, 359-365.
44. Putsep, K., Carlsson, G., Boman, H., & Andersson, M. (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study, The Lancet, 360, 1144-1149.
45. Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) Peroxynitrite-induced membrane lipid-peroxidation-the cytotoxic potential of superoxide and nitric-oxide, Arch Biochem Biophys, 288, 481-487.
46. Randell, S. H. & Boucher, R. C. (2006) Effective mucus clearance is essential for respiratory health, American J Respir Cell Mol Biol, 35, 20-28.
47. Ricciardolo, F. L., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) Nitric oxide in health and disease of the respiratory system, Physiol Rev, 84, 731-765.
48. Saura, M., Zaragoza, C., McMillan, A., Quick, R. A., Hohenadl, C., Lowenstein, J. M., & Lowenstein, C. J. (1999) An antiviral mechanism of nitric oxide: inhibition of a viral protease, Immunity, 10, 21-28.
49. Schutte, B. C. & McCray, P. B., Jr. (2002) beta-defensins in lung host defense, Annu Rev Physiol, 64, 709-748.
50. Selsted, M. E. & Ouellette, A. J. (2005) Mammalian defensins in the antimicrobial immune response, Nat Immunol, 6, 551-557.
51. Shaykhiev, R., Beisswenger, C., Kaendler, K., Senske, J., Puechner, A., Damm, T., Behr, J., & Bals, R. (2005) Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure, Am J Physiol Lung Cell Mol Physiol, 289, L842-L848.
52. Shu, Q., Shi, Z., Zhao, Z. Y., Chen, Z., Yao, H. P., Chen, Q. X., Hoeft, A., Stuber, F., & Fang, X. M. (2006) Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats, Shock, 26, 365-371.
53. Simpson, A. J., Maxwell, A. I., Govan, J. R., Haslett, C., & Sallenave, J. M. (1999) Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens, FEBS Lett, 452, 309-313.
54. Simpson, A. J., Wallace, W. A., Marsden, M. E., Govan, J. R., Porteous, D. J., Haslett, C., & Sallenave, J. M. (2001) Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection, J Immunol, 167, 1778-1786.
55. Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) A component of innate immunity prevents bacterial biofilm development, Nature, 417, 552-555.
56. Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid, Cell, 85, 229-236.
57. Starner, T. D., Barker, C. K., Jia, H. P., Kang, Y., & McCray, P. B., Jr. (2003) CCL20 is an inducible product of human airway epithelia with innate immune properties, Am J Respir Cell Mol Biol, 29, 627-633.
58. Taggart, C. C., Greene, C. M., Smith, S. G., Levine, R. L., McCray, P. B., Jr., O'Neill, S., & McElvaney, N. G. (2003) Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins, J Immunol, 171, 931-937.
59. Tjabringa, G. S., Aarbiou, J., Ninaber, D. K., Drijfhout, J. W., Sorensen, O. E., Borregaard, N., Rabe, K. F., & Hiemstra, P. S. (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor, J Immunol, 171, 6690-6696.
60. Tjabringa, G. S., Rabe, K. F., & Hiemstra, P. S. (2005) The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung, Pulm Pharmacol Ther, 18, 321-327.
61. Tjabringa, G. S., Ninaber, D. K., Drijfhout, J. W., Rabe, K. F., & Hiemstra, P. S. (2006) Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors, Int Arch Allergy Immunol, 140, 103-112.
62. Travis, S. M., Conway, B. A., Zabner, J., Smith, J. J., Anderson, N. N., Singh, P. K., Greenberg, E. P., & Welsh, M. J. (1999) Activity of abundant antimicrobials of the human airway, Am J Respir Cell Mol Biol, 20, 872-879.
63. Wallace, A. M., He, J. Q., Burkett, K. M., Ruan, J., Connett, J. E., Anthonisen, N. R., Pare, P. D., & Sandford, A. J. (2006) Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study, Respir Res, 7, 76.
64. Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., & White, J. H. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression, J Immunol, 173, 2909-2912.
65. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., Feathers, R. W., Chu, H., Lima, H., Jr., Fellermann, K., Ganz, T., Stange, E. F., & Bevins, C. L. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease, Proc Natl Acad Sci U S A, 102, 18129-18134.
66. Weiner, D. J., Bucki, R., & Janmey, P. A. (2003) The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin, Am J Respir Cell Mol Biol, 28, 738-745.
67. Williams, S. E., Brown, T. I., Roghanian, A., & Sallenave, J. M. (2006) SLPI and elafin: one glove, many fingers, Clin Sci (Lond), 110, 21-35.
68. Wright, J. R. (2005) Immunoregulatory functions of surfactant proteins, Nat Rev Immunol, 5, 58-68.
69. Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R. A., Schechter, N. M., Bonnart, C., Descargues, P., Hovnanian, A., & Gallo, R. L. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin, FASEB J, 20, 2068-2080.
70. Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity, J Leukoc Biol, 75, 39-48.
71. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms, Nature, 415, 389-395.
72. Zhou, H. D., Li, G. Y., Yang, Y. X., Li, X. L., Sheng, S. R., Zhang, W. L., & Zhao, J. (2006) Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain, Mol Immunol, 43, 864-871.